Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning
- 30 November 2021
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 191 (3) , 631-641
Abstract
Purpose Many women are being offered rapid genetic testing (RGT) for cancer predisposition genes, at the time of breast cancer diagnosis prior to surgery. The goal of this study was to determine if psychosocial functioning was affected in women receiving RGT for BRCA1 and BRCA2 at the time of breast cancer diagnosis. Methods Participants were women with invasive breast cancer diagnosed between 2013 and 2018, at four centres in Toronto, Canada. Eligible women were referred into the study by their surgeon at the time of diagnosis. Participants received pre-test genetic counselling and were offered RGT for BRCA1 and BRCA2. Standardized questionnaires (Impact of Event Scale and Hospital Anxiety and Depression Scale) were completed before genetic counselling, and follow-up questionnaires at one-week and one-year post-genetic test result disclosure (higher scores indicate higher symptoms). Results 1007 women had RGT; 60 women (6.0%) were found to have a BRCA1 or BRCA2 mutation, 80 women (7.9%) had a VUS, and 867 (86.1%) had a negative test result. At one-week post-testing, there were no differences in distress (p = 0.32), anxiety (p = 0.14), or depression (p = 0.42) between women with a BRCA1/2 mutation and those with a negative result. At one year, there were no differences in distress (p = 0.75) or anxiety (p = 0.13) between women with a BRCA1 or BRCA/2 mutation and those with a negative result. However, women with a BRCA1 or BRCA2 mutation had significantly lower depression scores compared to women with a negative result (p = 0.03). Conclusion For women who have RGT for BRCA1 and BRCA2 at the time of breast cancer diagnosis, identifying a BRCA1 or BRCA2 mutation does not impair psychosocial functioning in the short or long term.Keywords
Funding Information
- Canadian Institutes of Health Research
- peter gilgan centre for women’s cancers at women’s college hospital
This publication has 27 references indexed in Scilit:
- Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysisBMJ, 2014
- Cognitive and Psychological Impact of BRCA Genetic Counseling in Before and After Definitive Surgery Breast Cancer PatientsAnnals of Surgical Oncology, 2012
- A longitudinal study of psychosocial distress in breast cancer: Prevalence and risk factorsPsychology & Health, 2012
- Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriersBritish Journal of Cancer, 2011
- Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriersBreast Cancer Research and Treatment, 2011
- Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional rolePsycho-Oncology, 2009
- Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40European Journal of Cancer Care, 2005
- Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation CarriersJournal of Clinical Oncology, 2004
- Impact of BRCA1/BRCA2 Counseling and Testing on Newly Diagnosed Breast Cancer PatientsJournal of Clinical Oncology, 2004
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983